glp 1 and gip agonist Receptor Agonism Attenuates GLP-1 Receptor Induced Nausea Emesis in Preclinical Models — Hayes Lab Schematic illustration of monoagonists, dual
Description
doi: 10.1210/jc.2015-1176

Key results included: Sustained improvements in skin quality, hydration, and radiance Over 88% of participants loved how treatment maintained their facial structure 9 out of 10 participants would recommend it after GLP-1 weight loss Visible improvements lasting up to 9 months Sculptra stimulates collagen and gradually improves laxity, while HA fillers restore immediate structure in areas that flatten with weight loss

Participants were randomized to receive 3 mg, 7 mg, or 14 mg of oral semaglutide or 100 mg of sitagliptin once daily

Novo Nordisk A/S: CagriSema Demonstrated Superior HbA1c Reduction of 1.91 Percent Points and Weight Loss of 14.2 Percent in Adults with Type 2 Diabetes in the REIMAGINE 2 Trial

However, this pattern hasnt been seen in human clinical trials (Tran, 2017)
